-
Loading metrics
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin
-
Ryan Woodhouse ,
Roles Conceptualization, Writing – original draft, Writing – review & editing
* E-mail: rwoodhouse@foundationmedicine.com
Affiliation Regulatory Affairs, Foundation Medicine, Inc, Cambridge, Massachusetts, United States of America
⨯ - Meijuan Li,
- Jason Hughes,
- David Delfosse,
- Joel Skoletsky,
- Pei Ma,
- Wei Meng,
- Ninad Dewal,
- Coren Milbury,
- Travis Clark,
- Amy Donahue,
- Dan Stover,
- Mark Kennedy,
- Jennifer Dacpano-Komansky,
- Christine Burns,
- Christine Vietz,
- Brian Alexander,
- Priti Hegde,
- [ ... ],
- Lucas Dennis
- [ view all ]
- [ view less ]
http://orcid.org/0000-0002-0316-3759
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin
- Ryan Woodhouse,
- Meijuan Li,
- Jason Hughes,
- David Delfosse,
- Joel Skoletsky,
- Pei Ma,
- Wei Meng,
- Ninad Dewal,
- Coren Milbury,
- Travis Clark
x
- Published: September 25, 2020
- https://doi.org/10.1371/journal.pone.0237802